Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1996 Mar;117(6):1209–1221. doi: 10.1111/j.1476-5381.1996.tb16718.x

Interactions of 2,3-benzodiazepines and cyclothiazide at AMPA receptors: patch clamp recordings in cultured neurones and area CA1 in hippocampal slices.

G Rammes 1, D Swandulla 1, G L Collingridge 1, S Hartmann 1, C G Parsons 1
PMCID: PMC1909809  PMID: 8882618

Abstract

1. The 2,3-benzodiazepines GYKI 52466, GYKI 53405 and GYKI 53655 antagonized AMPA-induced currents in cultured superior colliculus neurones in a non use-dependent manner (steady state IC50s: GYKI 52466 9.8 +/- 0.6 microM; GYKI 53405 3.1 +/- 0.6 microM; GYKI 53655 0.8 +/- 0.1 microM). 2. Higher concentrations of all three antagonists slowed the onset kinetics and quickened the offset kinetics of AMPA-induced currents indicative of an allosteric interaction with the AMPA recognition site. 3. Cyclothiazide (3-300 microM) dramatically slowed desensitization of AMPA-induced currents and potentiated steady state currents (EC50 10.0 +/- 2.5 microM) to a much greater degree than peak currents. Both tau on and tau off were also increased by cyclothiazide in a concentration-dependent manner (EC50: tau on 42.1 +/- 4.5 microM; tau off 31.6 +/- 6.6 microM). 4. Cyclothiazide (10-100 microM) shifted the concentration-response curves of the 2,3-benzodiazepines to the right. For example, with 10 microM cyclothiazide the IC50s of GYKI 52466 and GYKI 53405 on steady-state AMPA-induced currents were 57.9 +/- 9.5 and 41.6 +/- 1.5 microM, respectively. 5. GYKI 53405 and GYKI 52466 concentration-dependently reversed the effects of cyclothiazide (100 microM) on offset kinetics (GYKI 53405 IC50 16.6 +/- 4.2 microM). However, the 2,3-benzodiazepines were unable to reintroduce desensitization in the presence of cyclothiazide and even concentration-dependently slowed the onset kinetics of AMPA responses further (GYKI 53405 EC50 8.0 +/- 2.8 microM). 6. GYKI 52466 decreased the peak amplitude of hippocampal area CA1 AMPA receptor-mediated excitatory postsynaptic currents (e.p.s.cs) (IC50 10.8 +/- 0.8 microM) with no apparent effect on response kinetics. Cyclothiazide prolonged the decay time constant of AMPA receptor-mediated e.p.s.cs (EC50 35.7 +/- 6.5 microM) with less pronounced effects in slowing e.p.s.c. onset kinetics and increasing e.p.s.c. amplitude. 7. Cyclothiazide (330 microM) shifted the concentration-response curve for the effects of GYKI 52466 on AMPA receptor-mediated e.p.s.c. peak amplitude to the right (GYKI 52466 IC50 26.9 +/- 9.4 microM). Likewise, GYKI 52466 (30-100 microM)) shifted the concentration-response curve for the effects of cyclothiazide on AMPA receptor-mediated e.p.s.c. decay time constants to the right. 8. In conclusion, cyclothiazide and the 2,3-benzodiazepines seem to bind to different sites on AMPA receptors but exert strong allosteric interactions with one another and with other domains such as the agonist recognition site. The interactions of GYKI 52466 and cyclothiazide on AMPA receptor-mediated e.p.s.cs in area CA1 of hippocampal slices provide evidence that the decay time constant of these synaptic events are not governed by desensitization.

Full text

PDF
1209

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Barnes J. M., Dev K. K., Henley J. M. Cyclothiazide unmasks AMPA-evoked stimulation of [3H]-L-glutamate release from rat hippocampal synaptosomes. Br J Pharmacol. 1994 Oct;113(2):339–341. doi: 10.1111/j.1476-5381.1994.tb16902.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bertolino M., Baraldi M., Parenti C., Braghiroli D., DiBella M., Vicini S., Costa E. Modulation of AMPA/kainate receptors by analogues of diazoxide and cyclothiazide in thin slices of rat hippocampus. Receptors Channels. 1993;1(4):267–278. [PubMed] [Google Scholar]
  3. Bisaga A., Krzascik P., Jankowska E., Palejko W., Kostowski W., Danysz W. Effect of glutamate receptor antagonists on N-methyl-D-aspartate- and (S)-alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid-induced convulsant effects in mice and rats. Eur J Pharmacol. 1993 Oct 5;242(3):213–220. doi: 10.1016/0014-2999(93)90244-c. [DOI] [PubMed] [Google Scholar]
  4. Boulton C. L., Irving A. J., Southam E., Potier B., Garthwaite J., Collingridge G. L. The nitric oxide--cyclic GMP pathway and synaptic depression in rat hippocampal slices. Eur J Neurosci. 1994 Oct 1;6(10):1528–1535. doi: 10.1111/j.1460-9568.1994.tb00543.x. [DOI] [PubMed] [Google Scholar]
  5. Chapman A. G., Smith S. E., Meldrum B. S. The anticonvulsant effect of the non-NMDA antagonists, NBQX and GYKI 52466, in mice. Epilepsy Res. 1991 Jul;9(2):92–96. doi: 10.1016/0920-1211(91)90018-b. [DOI] [PubMed] [Google Scholar]
  6. Chapman A. G., al-Zubaidy Z., Meldrum B. S. Aniracetam reverses the anticonvulsant action of NBQX and GYKI 52466 in DBA/2 mice. Eur J Pharmacol. 1993 Feb 9;231(2):301–303. doi: 10.1016/0014-2999(93)90465-t. [DOI] [PubMed] [Google Scholar]
  7. Chizh B. A., Cumberbatch M. J., Headley P. M. A comparison of intravenous NBQX and GYKI 53655 as AMPA antagonists in the rat spinal cord. Br J Pharmacol. 1994 Jul;112(3):843–846. doi: 10.1111/j.1476-5381.1994.tb13156.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Clements J. D., Lester R. A., Tong G., Jahr C. E., Westbrook G. L. The time course of glutamate in the synaptic cleft. Science. 1992 Nov 27;258(5087):1498–1501. doi: 10.1126/science.1359647. [DOI] [PubMed] [Google Scholar]
  9. Cumberbatch M. J., Chizh B. A., Headley P. M. AMPA receptors have an equal role in spinal nociceptive and non-nociceptive transmission. Neuroreport. 1994 Apr 14;5(8):877–880. doi: 10.1097/00001756-199404000-00006. [DOI] [PubMed] [Google Scholar]
  10. Danysz W., Zajaczkowski W., Parsons C.G. Modulation of learning processes by ionotropic glutamate receptor ligands. Behav Pharmacol. 1995 Aug;6(5-6):455–474. [PubMed] [Google Scholar]
  11. Desai M. A., Burnett J. P., Ornstein P. L., Schoepp D. D. Cyclothiazide acts at a site on the alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptor complex that does not recognize competitive or noncompetitive AMPA receptor antagonists. J Pharmacol Exp Ther. 1995 Jan;272(1):38–43. [PubMed] [Google Scholar]
  12. Desai M. A., Burnett J. P., Schoepp D. D. Cyclothiazide selectively potentiates AMPA- and kainate-induced [3H]norepinephrine release from rat hippocampal slices. J Neurochem. 1994 Jul;63(1):231–237. doi: 10.1046/j.1471-4159.1994.63010231.x. [DOI] [PubMed] [Google Scholar]
  13. Donevan S. D., Rogawski M. A. GYKI 52466, a 2,3-benzodiazepine, is a highly selective, noncompetitive antagonist of AMPA/kainate receptor responses. Neuron. 1993 Jan;10(1):51–59. doi: 10.1016/0896-6273(93)90241-i. [DOI] [PubMed] [Google Scholar]
  14. Donevan S. D., Yamaguchi S., Rogawski M. A. Non-N-methyl-D-aspartate receptor antagonism by 3-N-substituted 2,3-benzodiazepines: relationship to anticonvulsant activity. J Pharmacol Exp Ther. 1994 Oct;271(1):25–29. [PubMed] [Google Scholar]
  15. Engberg I., Tarnawa I., Durand J., Ouardouz M. An analysis of synaptic transmission to motoneurones in the cat spinal cord using a new selective receptor blocker. Acta Physiol Scand. 1993 Jun;148(2):97–100. doi: 10.1111/j.1748-1716.1993.tb09537.x. [DOI] [PubMed] [Google Scholar]
  16. Globus M. Y., Busto R., Martinez E., Valdés I., Dietrich W. D., Ginsberg M. D. Comparative effect of transient global ischemia on extracellular levels of glutamate, glycine, and gamma-aminobutyric acid in vulnerable and nonvulnerable brain regions in the rat. J Neurochem. 1991 Aug;57(2):470–478. doi: 10.1111/j.1471-4159.1991.tb03775.x. [DOI] [PubMed] [Google Scholar]
  17. Granger R., Staubli U., Davis M., Perez Y., Nilsson L., Rogers G. A., Lynch G. A drug that facilitates glutamatergic transmission reduces exploratory activity and improves performance in a learning-dependent task. Synapse. 1993 Dec;15(4):326–329. doi: 10.1002/syn.890150409. [DOI] [PubMed] [Google Scholar]
  18. Greenamyre J. T., Maragos W. F., Albin R. L., Penney J. B., Young A. B. Glutamate transmission and toxicity in Alzheimer's disease. Prog Neuropsychopharmacol Biol Psychiatry. 1988;12(4):421–430. doi: 10.1016/0278-5846(88)90102-9. [DOI] [PubMed] [Google Scholar]
  19. Hall R. A., Kessler M., Quan A., Ambros-Ingerson J., Lynch G. Cyclothiazide decreases [3H]AMPA binding to rat brain membranes: evidence that AMPA receptor desensitization increases agonist affinity. Brain Res. 1993 Nov 19;628(1-2):345–348. doi: 10.1016/0006-8993(93)90978-v. [DOI] [PubMed] [Google Scholar]
  20. Hestrin S. Activation and desensitization of glutamate-activated channels mediating fast excitatory synaptic currents in the visual cortex. Neuron. 1992 Nov;9(5):991–999. doi: 10.1016/0896-6273(92)90250-h. [DOI] [PubMed] [Google Scholar]
  21. Hoyt K. R., Rajdev S., Fattman C. L., Reynolds I. J. Cyclothiazide modulates AMPA receptor-mediated increases in intracellular free Ca2+ and Mg2+ in cultured neurons from rat brain. J Neurochem. 1995 May;64(5):2049–2056. doi: 10.1046/j.1471-4159.1995.64052049.x. [DOI] [PubMed] [Google Scholar]
  22. Isaacson J. S., Nicoll R. A. Aniracetam reduces glutamate receptor desensitization and slows the decay of fast excitatory synaptic currents in the hippocampus. Proc Natl Acad Sci U S A. 1991 Dec 1;88(23):10936–10940. doi: 10.1073/pnas.88.23.10936. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Ito I., Tanabe S., Kohda A., Sugiyama H. Allosteric potentiation of quisqualate receptors by a nootropic drug aniracetam. J Physiol. 1990 May;424:533–543. doi: 10.1113/jphysiol.1990.sp018081. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Jonas P., Sakmann B. Glutamate receptor channels in isolated patches from CA1 and CA3 pyramidal cells of rat hippocampal slices. J Physiol. 1992 Sep;455:143–171. doi: 10.1113/jphysiol.1992.sp019294. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Kiskin N. I., Krishtal O. A., Tsyndrenko AYa Excitatory amino acid receptors in hippocampal neurons: kainate fails to desensitize them. Neurosci Lett. 1986 Jan 30;63(3):225–230. doi: 10.1016/0304-3940(86)90360-5. [DOI] [PubMed] [Google Scholar]
  26. Lee C. R., Benfield P. Aniracetam. An overview of its pharmacodynamic and pharmacokinetic properties, and a review of its therapeutic potential in senile cognitive disorders. Drugs Aging. 1994 Mar;4(3):257–273. doi: 10.2165/00002512-199404030-00007. [DOI] [PubMed] [Google Scholar]
  27. Livsey C. T., Costa E., Vicini S. Glutamate-activated currents in outside-out patches from spiny versus aspiny hilar neurons of rat hippocampal slices. J Neurosci. 1993 Dec;13(12):5324–5333. doi: 10.1523/JNEUROSCI.13-12-05324.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Löscher W., Hönack D. Effects of the non-NMDA antagonists NBQX and the 2,3-benzodiazepine GYKI 52466 on different seizure types in mice: comparison with diazepam and interactions with flumazenil. Br J Pharmacol. 1994 Dec;113(4):1349–1357. doi: 10.1111/j.1476-5381.1994.tb17146.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. May P. C., Robison P. M. Cyclothiazide treatment unmasks AMPA excitotoxicity in rat primary hippocampal cultures. J Neurochem. 1993 Mar;60(3):1171–1174. doi: 10.1111/j.1471-4159.1993.tb03272.x. [DOI] [PubMed] [Google Scholar]
  30. May P. C., Robison P. M. GYKI 52466 protects against non-NMDA receptor-mediated excitotoxicity in primary rat hippocampal cultures. Neurosci Lett. 1993 Apr 2;152(1-2):169–172. doi: 10.1016/0304-3940(93)90510-r. [DOI] [PubMed] [Google Scholar]
  31. Misgeld U., Müller W., Polder H. R. Potentiation and suppression by eserine of muscarinic synaptic transmission in the guinea-pig hippocampal slice. J Physiol. 1989 Feb;409:191–206. doi: 10.1113/jphysiol.1989.sp017492. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Moncada C., Arvin B., Le Peillet E., Meldrum B. S. Non-NMDA antagonists protect against kainate more than AMPA toxicity in the rat hippocampus. Neurosci Lett. 1991 Dec 9;133(2):287–290. doi: 10.1016/0304-3940(91)90590-p. [DOI] [PubMed] [Google Scholar]
  33. Moudy A. M., Yamada K. A., Rothman S. M. Rapid desensitization determines the pharmacology of glutamate neurotoxicity. Neuropharmacology. 1994 Aug;33(8):953–962. doi: 10.1016/0028-3908(94)90153-8. [DOI] [PubMed] [Google Scholar]
  34. Ouardouz M., Durand J. GYKI 52466 antagonizes glutamate responses but not NMDA and kainate responses in rat abducens motoneurones. Neurosci Lett. 1991 Apr 15;125(1):5–8. doi: 10.1016/0304-3940(91)90115-a. [DOI] [PubMed] [Google Scholar]
  35. Ouardouz M., Durand J. Involvement of AMPA receptors in trigeminal post-synaptic potentials recorded in rat abducens motoneurons in vivo. Eur J Neurosci. 1994 Nov 1;6(11):1662–1668. doi: 10.1111/j.1460-9568.1994.tb00558.x. [DOI] [PubMed] [Google Scholar]
  36. Palmer A. J., Lodge D. Cyclothiazide reverses AMPA receptor antagonism of the 2,3-benzodiazepine, GYKI 53655. Eur J Pharmacol. 1993 Jan 15;244(2):193–194. doi: 10.1016/0922-4106(93)90027-7. [DOI] [PubMed] [Google Scholar]
  37. Palmer A. M., Gershon S. Is the neuronal basis of Alzheimer's disease cholinergic or glutamatergic? FASEB J. 1990 Jul;4(10):2745–2752. doi: 10.1096/fasebj.4.10.2165009. [DOI] [PubMed] [Google Scholar]
  38. Parsons C. G., Gruner R., Rozental J. Comparative patch clamp studies on the kinetics and selectivity of glutamate receptor antagonism by 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinoxaline (NBQX) and 1-(4-amino-phenyl)-4-methyl-7,8-methyl-endioxyl-5H-2,3-benzodiaze pine (GYKI 52466). Neuropharmacology. 1994 May;33(5):589–604. doi: 10.1016/0028-3908(94)90163-5. [DOI] [PubMed] [Google Scholar]
  39. Partin K. M., Patneau D. K., Mayer M. L. Cyclothiazide differentially modulates desensitization of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor splice variants. Mol Pharmacol. 1994 Jul;46(1):129–138. [PubMed] [Google Scholar]
  40. Partin K. M., Patneau D. K., Winters C. A., Mayer M. L., Buonanno A. Selective modulation of desensitization at AMPA versus kainate receptors by cyclothiazide and concanavalin A. Neuron. 1993 Dec;11(6):1069–1082. doi: 10.1016/0896-6273(93)90220-l. [DOI] [PubMed] [Google Scholar]
  41. Patneau D. K., Mayer M. L., Jane D. E., Watkins J. C. Activation and desensitization of AMPA/kainate receptors by novel derivatives of willardiine. J Neurosci. 1992 Feb;12(2):595–606. doi: 10.1523/JNEUROSCI.12-02-00595.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Patneau D. K., Mayer M. L. Kinetic analysis of interactions between kainate and AMPA: evidence for activation of a single receptor in mouse hippocampal neurons. Neuron. 1991 May;6(5):785–798. doi: 10.1016/0896-6273(91)90175-y. [DOI] [PubMed] [Google Scholar]
  43. Patneau D. K., Mayer M. L. Structure-activity relationships for amino acid transmitter candidates acting at N-methyl-D-aspartate and quisqualate receptors. J Neurosci. 1990 Jul;10(7):2385–2399. doi: 10.1523/JNEUROSCI.10-07-02385.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Patneau D. K., Vyklicky L., Jr, Mayer M. L. Hippocampal neurons exhibit cyclothiazide-sensitive rapidly desensitizing responses to kainate. J Neurosci. 1993 Aug;13(8):3496–3509. doi: 10.1523/JNEUROSCI.13-08-03496.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Pelletier M. R., Hablitz J. J. Altered desensitization produces enhancement of EPSPs in neocortical neurons. J Neurophysiol. 1994 Aug;72(2):1032–1036. doi: 10.1152/jn.1994.72.2.1032. [DOI] [PubMed] [Google Scholar]
  46. Pizzi M., Fallacara C., Arrighi V., Memo M., Spano P. F. Attenuation of excitatory amino acid toxicity by metabotropic glutamate receptor agonists and aniracetam in primary cultures of cerebellar granule cells. J Neurochem. 1993 Aug;61(2):683–689. doi: 10.1111/j.1471-4159.1993.tb02173.x. [DOI] [PubMed] [Google Scholar]
  47. Raman I. M., Zhang S., Trussell L. O. Pathway-specific variants of AMPA receptors and their contribution to neuronal signaling. J Neurosci. 1994 Aug;14(8):4998–5010. doi: 10.1523/JNEUROSCI.14-08-04998.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Rammes G., Parsons C., Müller W., Swandulla D. Modulation of fast excitatory synaptic transmission by cyclothiazide and GYKI 52466 in the rat hippocampus. Neurosci Lett. 1994 Jul 4;175(1-2):21–24. doi: 10.1016/0304-3940(94)91068-5. [DOI] [PubMed] [Google Scholar]
  49. Rogawski M. A. Therapeutic potential of excitatory amino acid antagonists: channel blockers and 2,3-benzodiazepines. Trends Pharmacol Sci. 1993 Sep;14(9):325–331. doi: 10.1016/0165-6147(93)90005-5. [DOI] [PubMed] [Google Scholar]
  50. Sheardown M. J., Nielsen E. O., Hansen A. J., Jacobsen P., Honoré T. 2,3-Dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinoxaline: a neuroprotectant for cerebral ischemia. Science. 1990 Feb 2;247(4942):571–574. doi: 10.1126/science.2154034. [DOI] [PubMed] [Google Scholar]
  51. Smith S. E., Dürmüller N., Meldrum B. S. The non-N-methyl-D-aspartate receptor antagonists, GYKI 52466 and NBQX are anticonvulsant in two animal models of reflex epilepsy. Eur J Pharmacol. 1991 Aug 29;201(2-3):179–183. doi: 10.1016/0014-2999(91)90342-n. [DOI] [PubMed] [Google Scholar]
  52. Smith S. E., Meldrum B. S. Cerebroprotective effect of a non-N-methyl-D-aspartate antagonist, GYKI 52466, after focal ischemia in the rat. Stroke. 1992 Jun;23(6):861–864. doi: 10.1161/01.str.23.6.861. [DOI] [PubMed] [Google Scholar]
  53. Staubli U., Ambros-Ingerson J., Lynch G. Receptor changes and LTP: an analysis using aniracetam, a drug that reversibly modifies glutamate (AMPA) receptors. Hippocampus. 1992 Jan;2(1):49–57. doi: 10.1002/hipo.450020107. [DOI] [PubMed] [Google Scholar]
  54. Staubli U., Rogers G., Lynch G. Facilitation of glutamate receptors enhances memory. Proc Natl Acad Sci U S A. 1994 Jan 18;91(2):777–781. doi: 10.1073/pnas.91.2.777. [DOI] [PMC free article] [PubMed] [Google Scholar]
  55. Stäubli U., Perez Y., Xu F. B., Rogers G., Ingvar M., Stone-Elander S., Lynch G. Centrally active modulators of glutamate receptors facilitate the induction of long-term potentiation in vivo. Proc Natl Acad Sci U S A. 1994 Nov 8;91(23):11158–11162. doi: 10.1073/pnas.91.23.11158. [DOI] [PMC free article] [PubMed] [Google Scholar]
  56. Swandulla D., Misgeld U. Development and properties of synaptic mechanisms in a network of rat hypothalamic neurons grown in culture. J Neurophysiol. 1990 Sep;64(3):715–726. doi: 10.1152/jn.1990.64.3.715. [DOI] [PubMed] [Google Scholar]
  57. Szabó G., Henley J. M. Binding of the AMPA receptor antagonist [3H]GYKI 53405 to Xenopus brain membranes. Neuroreport. 1993 Oct 25;5(1):93–94. doi: 10.1097/00001756-199310000-00026. [DOI] [PubMed] [Google Scholar]
  58. Tang C. M., Shi Q. Y., Katchman A., Lynch G. Modulation of the time course of fast EPSCs and glutamate channel kinetics by aniracetam. Science. 1991 Oct 11;254(5029):288–290. doi: 10.1126/science.254.5029.288. [DOI] [PubMed] [Google Scholar]
  59. Tarnawa I., Molnár P., Gaál L., Andrási F. Inhibition of hippocampal field potentials by GYKI 52466 in vitro and in vivo. Acta Physiol Hung. 1992;79(2):163–169. [PubMed] [Google Scholar]
  60. Trussell L. O., Fischbach G. D. Glutamate receptor desensitization and its role in synaptic transmission. Neuron. 1989 Aug;3(2):209–218. doi: 10.1016/0896-6273(89)90034-2. [DOI] [PubMed] [Google Scholar]
  61. Trussell L. O., Zhang S., Raman I. M. Desensitization of AMPA receptors upon multiquantal neurotransmitter release. Neuron. 1993 Jun;10(6):1185–1196. doi: 10.1016/0896-6273(93)90066-z. [DOI] [PubMed] [Google Scholar]
  62. Verdoorn T. A., Burnashev N., Monyer H., Seeburg P. H., Sakmann B. Structural determinants of ion flow through recombinant glutamate receptor channels. Science. 1991 Jun 21;252(5013):1715–1718. doi: 10.1126/science.1710829. [DOI] [PubMed] [Google Scholar]
  63. Vyklicky L., Jr, Patneau D. K., Mayer M. L. Modulation of excitatory synaptic transmission by drugs that reduce desensitization at AMPA/kainate receptors. Neuron. 1991 Dec;7(6):971–984. doi: 10.1016/0896-6273(91)90342-w. [DOI] [PubMed] [Google Scholar]
  64. Wilding T. J., Huettner J. E. Differential antagonism of alpha-amino-3-hydroxy-5-methyl-4- isoxazolepropionic acid-preferring and kainate-preferring receptors by 2,3-benzodiazepines. Mol Pharmacol. 1995 Mar;47(3):582–587. [PubMed] [Google Scholar]
  65. Wong L. A., Mayer M. L. Differential modulation by cyclothiazide and concanavalin A of desensitization at native alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid- and kainate-preferring glutamate receptors. Mol Pharmacol. 1993 Sep;44(3):504–510. [PubMed] [Google Scholar]
  66. Yamada K. A., Tang C. M. Benzothiadiazides inhibit rapid glutamate receptor desensitization and enhance glutamatergic synaptic currents. J Neurosci. 1993 Sep;13(9):3904–3915. doi: 10.1523/JNEUROSCI.13-09-03904.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  67. Yamaguchi S., Donevan S. D., Rogawski M. A. Anticonvulsant activity of AMPA/kainate antagonists: comparison of GYKI 52466 and NBOX in maximal electroshock and chemoconvulsant seizure models. Epilepsy Res. 1993 Jul;15(3):179–184. doi: 10.1016/0920-1211(93)90054-b. [DOI] [PubMed] [Google Scholar]
  68. Zivkovic I., Thompson D. M., Bertolino M., Uzunov D., DiBella M., Costa E., Guidotti A. 7-Chloro-3-methyl-3-4-dihydro-2H-1,2,4 benzothiadiazine S,S-dioxide (IDRA 21): a benzothiadiazine derivative that enhances cognition by attenuating DL-alpha-amino-2,3-dihydro-5-methyl-3-oxo-4-isoxazolepropanoic acid (AMPA) receptor desensitization. J Pharmacol Exp Ther. 1995 Jan;272(1):300–309. [PubMed] [Google Scholar]
  69. Zorumski C. F., Yamada K. A., Price M. T., Olney J. W. A benzodiazepine recognition site associated with the non-NMDA glutamate receptor. Neuron. 1993 Jan;10(1):61–67. doi: 10.1016/0896-6273(93)90242-j. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES